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Cardiovascular cells5-hydroxymethylcytosine (5hmC), an oxidized derivative of 5-methylcytosine (5mC), has been implicated as an
important epigenetic regulator of mammalian development. Current procedures use DNA sequencing methods
to discriminate 5hmC from5mC, limiting their accessibility to the scientiﬁc community. Herewe report amethod
that combines TET-assisted bisulﬁte conversionwith Illumina 450 K DNAmethylation arrays for a low-cost high-
throughput approach that distinguishes 5hmC and 5mC signals at base resolution. Implementing this approach,
termed “TAB-array”, we assessed DNA methylation dynamics in the differentiation of human pluripotent stem
cells into cardiovascular progenitors and neural precursor cells. With the ability to discriminate 5mC and
5hmC, we identiﬁed a large number of novel dynamically methylated genomic regions that are implicated in
the development of these lineages. The increased resolution and accuracy afforded by this approach provides a
powerful means to investigate the distinct contributions of 5mC and 5hmC in human development and disease.
© 2014 Elsevier Inc. All rights reserved.1. Introduction
Dramatic epigenetic changes occur during human embryonic devel-
opment. Human pluripotent stem cells (hPSCs; embryonic stem cells
and induced pluripotent stem cells) are a valuable model of epigenetic
regulation in development because they can be directed in vitro to dif-
ferentiate into many different cell types. DNA methylation has been
shown to be an important epigenetic modiﬁcation that regulates vital
cellular processes including gene expression, retrotransposon silencing
and imprinting. Mostmethylation occurs on cytosines in a CpG dinucle-
otide context, although non-CpG methylation (CpH), especially CpA
methylation, is common in hPSCs and the brain [1–3]. DNAmethylation
has been shown to change dramatically as hPSCs differentiate [2]. In un-
differentiated hPSCs, genes coding for lineage-specifying factors arestitute, Center for Regenerative
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ina Way, San Diego, CA 92121.
n@illumina.com (J.-B. Fan).uniformly methylated; as the cells differentiate, methylation increases
in the promoters of pluripotency genes, while DNA methylation of re-
gions associated with regulation of lineage-speciﬁc genes decreases in
a cell type-speciﬁc manner [4].
Recently, an oxidized derivative of DNA methylation, 5-hydroxy-
methylcytosine (5hmC), has come into the spotlight and we are just
now beginning to investigate its signiﬁcance. 5hmC marks are found to
be highest in speciﬁc types of neurons and in hPSCs, with 5hmC present
on 0.7 and 0.4% of all cytosines in these cell types, respectively [5–7].
The Ten Eleven Translocation (TET) dioxygenases have been identiﬁed
as the enzymes that convert 5-methylcytosine (5mC) to 5hmC [7,8].
Like most 5mC methylation, 5hmC typically occurs at CpG dinucleotides.
Several lines of evidence suggest that the TET proteins, and therefore
5hmC, play an important role in regulating the pluripotent state. It
was recently shown that TET1 is dramatically induced during
reprogramming of somatic cells to pluripotency and that knockdown
of TET1 impedes the reprogramming process [9,10]. Additionally, TET1
can substitute for POU5F1 during reprogramming when MYC, KLF4
and SOX2 are also supplied [9]. Knockdown of the TET proteins in
murine hPSCs induced precocious differentiation and increased 5mC
in the promoters of pluripotency genes [8,11]. Collectively, these
359K.L. Nazor et al. / Genomics 104 (2014) 358–367observations implicate the TET proteins, and 5hmC, as critical factors in
the earliest stages of mammalian development.
While classicalmodels of gene regulation highlight a clear repressive
role for DNA methylation, with 5mC localized to heterochromatic
stretches of the genome, early evidence suggests that 5hmC may have
a functional association with euchromatin [11–13]. In stem cells,
5hmC has been shown to be highly enriched in bivalent promoters,
which are deﬁned by co-localization of H3K4me3 and H3K27me3 his-
tone modiﬁcations [14–17]. Bivalency is considered to be a means to
poise critical lineage-specifying genes for activation or silencing in re-
sponse to speciﬁc developmental cues. On one hand, the presence of
5hmC in these regions could support the notion that 5hmC exists as
an intermediate in a DNA demethylation cascade. On the other hand,
the overlap of 5hmC with bivalent domains could support a role for
5hmC in establishing euchromatin and/or in the recruitment of tran-
scription factors at critical stages of development. Additional evidence
suggests a wider role for 5hmC beyond being an intermediary of DNA
de-methylation. 5hmC has been detected in promoters and enhancers
of actively transcribed genes in adult tissues [5,12,18,19] and it is abun-
dant in terminally differentiated neurons in the brain [6]. Thus, existing
evidence suggests that 5hmC may have a diverse, context-dependent
set of functions. (See also reviews by Ficz and Pfeifer in this issue).
Resolving differences between 5mC and 5hmC will be critical in es-
tablishing a better understanding of how cytosine modiﬁcations con-
tribute to the regulation of differentiation. The standard technique for
studying DNA methylation is bisulﬁte treatment, which deaminates
unmethylated cytosines to uracil (read as T following genome ampliﬁ-
cation) but does not affect 5mC or 5hmC, which are read as C. Subse-
quent sequencing or array-based approaches allow identiﬁcation of
methylated cytosines at single base resolution, but more complex tech-
nologies are required to distinguish 5hmC from 5mC. Several afﬁnity-
capture techniques have been developed for identiﬁcation of 5hmC-
enriched genomic regions [15,18]. A recent development, TET-Assisted
Bisulﬁte sequencing (TAB-seq), has greatly improved mapping of
5hmC [14]; thereby permitting unbiased, genome-wide mapping of
5hmC at single-base resolution.
These technical advances have provided a powerful toolset for
detailed investigations into 5hmC function. However, the considerable
costs of sequencing and bioinformatic expertise required of its analysis
limit the availability of protocols that discriminate 5hmC from 5mC.
To make detailed mapping of 5hmC more accessible, we combined
TAB conversion with DNA methylation proﬁling on the Illumina
Inﬁnium HumanMethylation450K BeadChip (450 K array). This meth-
od, called “TAB-array” provides a high-throughput method for analyz-
ing both 5mC and 5hmC at less than 10% of the cost of sequence-
based approaches [14,20,21]. The Illumina Inﬁnium arrays contain
internal quality control measures and can be easily analyzed with pow-
erful user-friendly analysis packages in the R statistical environment
[22–24].
We have detected dynamic methylation in the differentiation of
human induced pluripotent stem cells (iPSCs) along two distinct line-
ages, cardiovascular progenitor cells (CVPs) and neural precursor cells
(NPCs) using standard bisulﬁte conversion proﬁling techniques. How-
ever, assessment of these cell types using the TAB-array approach
showed thatwe had initially underestimated the extent and complexity
of dynamic methylation among these cell types. With the ability to
distinguish 5hmC from 5mC, we discovered, for example, that many re-
gions of the genome identiﬁed as being 5mC in both lineages via stan-
dard methods, actually contained 5hmC in one lineage and 5mC in the
other. Remarkably, we found that a majority of the genomic regions
with developmentally dynamic 5mC among these cell types also
displayed dynamic 5hmC. This suggests that 5hmC plays an active role
in lineage choice during human development. Further analysis of a
wider variety of lineages and stages of hPSC differentiation will allow
us to better understand the epigenetic mechanisms underlying human
cellular differentiation. With its lower cost and decrease in complexityof analysis, the TAB-array method will enable a greater number of in-
vestigations into 5hmC vs. 5mC function and improve our understand-
ing of the role of differential DNA methylation in diverse cellular
contexts.
2. Results
In order to discriminate 5hmC from5mCusingmethylationmicroar-
rays, we adapted a previously reported sequencing-based method [14].
As illustrated in Fig. 1, genomic DNA from each biological sample was
split into two fractions for different downstream processing steps. One
fraction was processed for standard bisulﬁte conversion, which deami-
nates both 5mC and 5hmC. This process identiﬁed cytosines as methyl-
ated or not methylated, without distinguishing between 5mC and
5hmC. The other fraction was used for TET-Assisted Bisulﬁte (TAB) con-
version; DNAwas ﬁrst glucosylated to protect 5hmC, and then oxidized
by TET1, followed by bisulﬁte treatment. Each replicate was then proc-
essed through the Illumina Inﬁnium DNA methylation workﬂow and
hybridized to 450 K arrays.
Glucosylation of 5hmC is a critical step in the TAB-array procedure.
Therefore, we determinedwhether this treatment alone had any effects
on DNA methylation. DNA was isolated from two biological replicates
of human dermal ﬁbroblasts (HDFs) and processed as described
above, with the exception that the TAB treatment was terminated fol-
lowing glucosylation, prior to oxidation. Upon examination of the nor-
malized Beta values in a scatterplot, we observed that the glucosylated
samples were as similar to the untreated control samples as they were
to each other (R ≥ 0.995, Fig. S1). Therefore, protection of 5hmC via
glucosylation has no adverse effect on the stability of either 5hmC or
5mC.
Considering that 5hmC levels have been reported to be very high in
undifferentiated hPSCs and that hypomethylated genomic regions can
be used to distinguish unrelated tissue types, we reasoned that 5hmC
may play an important role in the activation of tissue-speciﬁc gene ex-
pression programs. To test this idea, we used an hPSC-basedmodel sys-
tem of lineage diversiﬁcation. Speciﬁcally, two populations of human
undifferentiated iPSCs were split three ways; a third of each population
was harvested for proﬁling of the pluripotent state, while the two re-
maining fractions were kept in culture under conditions that promote
differentiation into either cardiovascular (CVPs) or neural precursors
(NPCs) for an additional 5 and 9 days, respectively. Undifferentiated
cells were conﬁrmed to be pluripotent as indicated by PluriTestTM [35]
and the expression of the cell surface marker of SSEA-4 and NANOG
(Fig. 2, top) [25,26]. In contrast, the CVPs expressed markers consistent
with a CVP identity such as ISL-1 and NKX2.5 (Fig. 2, middle) [27,28].
The cells that differentiated along a neural lineage show expression of
NESTIN and PAX6 (Fig. 2, bottom), as expected for NPCs. Undifferentiat-
ed iPSCs, CVPs, and NPCs were analyzed by the TAB-array approach
outlined in Fig. 1.
Prior to normalization and processing of the standard 450 K
methylation and TAB-array data, we ﬁrst examined the underlying dis-
tributions of the raw Beta values. As expected, the standard 450 K data
ﬁt a bimodal continuous distribution, with local maxima near the
unmethylated (Beta = 0) and fully methylated (Beta = 1) extremes
of the distribution (Fig. 3A). The TAB-array data appeared tomore close-
ly ﬁt a unimodal distribution, with the exception of a small shoulder in
the raw TAB-array samples density curve, near Beta = 0.05 (Fig. 3B,
Fig. S2A). It was previously reported that approximately 80% of 5hmC
was asymmetric across the genome, compared to only 8% for 5mC
[14]. Therefore, we reasoned that the observed unimodal distribution
was likely biological and not technical in nature. Given the striking dif-
ferences in the distribution of these modiﬁcations, the standard 450 K
and TAB-array data were independently normalized using the subset-
quantile within array normalization (SWAN) method (Fig. 3C–D) [24].
Comparison of the raw and normalized TAB-array data showed the
small shoulder, near Beta = 0.05 in the raw data, resolved with
Fig. 1.Diagram of the TAB-array approach. Genomic DNAwas prepared from each biological sample and split into two fractions. One fraction (Sample A) was bisulﬁte converted and an-
alyzed by hybridization to the Illumina Inﬁnium450 K DNAMethylation BeadChip. Comparison to untreated DNA (not shown) allowed identiﬁcation of methylated cytosines. The second
fraction (Sample B)was glucosylated, protecting the 5hmC (hmC) but not the 5mC (mC) fromoxidation by the TET1 enzyme. After bisulﬁte treatment, these samples are also hybridized to
arrays. In the example, unmethylated cytosines were converted to thymidines by bisulﬁte treatment and ampliﬁcation. In the absence of TAB treatment, both 5hmC and 5mC were
protected and remain as cytosines. TAB treatment protected the 5hmC, while the 5mCwas oxidized and converted by sodium bisulﬁte to thymidine. By comparing the hybridization re-
sults in the two samples, 5hmC could be distinguished from 5mC. WGA: whole genome ampliﬁcation.
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the standard 450 K array data, we took a closer look at the probes com-
prising this shoulder in the density curve. As CpG density has been
shown to be inversely correlated with DNAmethylation [29], we calcu-
lated CpG density across a 250 bp window centered on each probe and
binned the probes into pentiles of increasing CpG density (Fig. S2B–C).
Re-plotting of the Beta density curves for these data according to CpG
density pentiles showed that this small shoulder in the TAB-array datawas primarily from probes in the ﬁfth CpG density pentile, although
a small bump could also be seen in probes of the fourth pentile
(Fig. S2D, green arrows). Interestingly, a less pronounced bump in the
standard density curve was also apparent in the ﬁfth CpG density
pentile (Fig. S2D, red arrow), which was not apparent in the data as a
whole. Therefore, we concluded that this feature in the distribution of
5hmCBeta densitywasnot technical artifact, but instead reﬂected an in-
verse correlation between 5hmC and CpG density that was stronger
Fig. 2.Characterization of undifferentiatedpluripotent stemcells, cardiovascular progenitors andneural progenitors. Undifferentiated iPSCswere immunolabeled for pluripotencymarkers
including NANOG (top; green) and SSEA-4 (top; red). A merged image of NANOG, SSEA-4 and a blue nuclear stain is shown at 20Xmagniﬁcation (top; right). CVPs were immunolabeled
with ISL1/2 (middle; green) and NKX2.5 (middle; red). A merged image of ISL1/2, NKX2.5 and a blue nuclear stain is shown at 10X magniﬁcation (middle; right). NPCs were
immunolabeled with NESTIN (bottom; green) and PAX6 (bottom; red). A merged image of NESTIN, PAX6 and a blue nuclear stain is shown at 10× magniﬁcation (bottom; right).
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CpG density-dependent assumptions about variance in its normaliza-
tion procedure, further supporting the independent normalization of
TAB-array and standard 450 K array methylation data.
Because dynamic epigenetic changes accompany differentiation, we
reasoned that some of the most biologically relevant changes in DNA
methylation would be missed if 5mC and 5hmC could not be distin-
guished. For example, 5hmC is enriched near bivalent chromatin,
which can arise at any point in development as progenitor cells set
the stage for successive fate choice [15]. In such cases, the “poising” of
these bivalent promoters would likely be associated with the conver-
sion of 5mC to 5hmC. However, without the ability to discriminate
these two methylated forms, any losses of 5mC would be masked in
the data by concomitant gains in 5hmC. To obtain a more accurate rep-
resentation of the distribution of 5mC prior to statistical analyses of
these data, we subtracted the TAB-array signal from each biological
sample's corresponding signal that was generated using standard
bisulﬁte conversion. This signiﬁcantly altered the distribution of
Beta values in the 5hmC-corrected 5mC data (henceforth, 5mC)
(Fig. 3E). Less than 1.0% of all probes were overcorrected to a Beta
value b −0.05 (4482/478767 probes), and less than 0.17% to a Beta
value b−0.1 (806/478767 probes). Over-corrected probes were reset
to a Beta value of 0.001, ﬂagged, and processed with the remainder of
the data. The sample correlation matrix in Fig. 3F is based on the top
50% most variable probes (~225,000) on the array. Among replicate
samples, the lowest observed correlation was R = 0.8. For 5hmC the
correlationwas 0.87, 0.88 and 0.80 for iPSCs, CVPs andNPCs, respective-
ly. The corrected 5mC correlations were 0.94, 0.94, and 0.90.
To examine dynamically methylated cytosines accompanying the
differentiation of iPSCs into CVPs and NPCs, the 5hmC and 5mC datawere analyzed using Limma in R [22,23]. In Limma, each probe is ﬁtted
to a linear model and empirical Bayes methods are used to smooth the
standard errors, allowing for more accurate detection of differentially
methylated probes or expressed genes. As the 5mC and 5hmC data
had drastically different distributions, these data were each analyzed
separately to avoid over- and under-estimation of error in the 5mC
and 5hmCdata, respectively. Based on our experience in analyzing stan-
dard Illumina 450 KMethylation array data, we chose cutoffs at p b 0.01
for all comparisons and also required that ΔBeta ≥ 0.3 for 5mC, and
ΔBeta ≥ 0.2 for 5hmC. Additionally, the uncorrected 5mC data were
processed in the same manner as the corrected 5mC data for quality
assurance.
Fig. 4 compares the outcome of the TAB-array method to standard
bisulﬁte conversion. Both approaches identiﬁed a common set of 5378
(A), 6704(B), and 10013(C) dynamically methylated loci, in CVPs,
NPCs or in the union of the two, respectively (Table S1). The TAB-
array method identiﬁed an additional 7924, 7268, 12365 dynamically
methylated loci, in CVPs, NPCs or in the union of the two, compared to
only 917, 1190, and 1605 unique to the standard method. In total, ap-
plication of the TAB-array approach and correction of 5mC Beta
values led to identiﬁcation of twice as many differentially methylat-
ed loci compared to standard methods ((12365 + 10013) / (1605
+ 10013) Fig. 4C). Of the probes that were uniquely signiﬁcant using
standardmethods, 75% (1240/1650)would have been called signiﬁcant
in the 5mC TAB-array data at a slightly reducedΔBeta threshold (≥0.2).
However, only 33% (4092/12365) of the probes that were uniquely sig-
niﬁcant in the TAB-array data would have been called signiﬁcant in the
standard bisulﬁte data at this reduced threshold. We determined that
the overcorrection of 5mC values during the normalization process
had negligible impact on analytical outcome, as only 20/78 signiﬁcant
Fig. 3. Normalization and identiﬁcation of differentially methylated cytosines in TAB-array data. 5hmC and standard 5mC data were initially independently normalized using the SWAN
method in R to generate Beta Values. For each pair of fractions from the same biological sample, 5hmC-speciﬁc Beta values were subtracted from the corresponding 5mC replicate Beta
values across all probes in order to remove 5hmC signal from the 5mC data. Differentially methylated cytosines were called independently for 5mC and 5hmC data using Limma.
(A) Global density plot for all standard bisulﬁte conversion samples, prior to normalization. (B) Global density plot for all TAB-samples, prior to normalization. The green arrow identiﬁes
a unique feature of the Beta density distribution that is further analyzed in Fig. S2. (C) Global density plot for all standard bisulﬁte conversion samples, after normalization. (D) Global den-
sity plot for all TAB-samples, after normalization. (E) Global density plot for all standard bisulﬁte conversion samples, following correction for 5hmC signal contribution. (F) A correlation
matrix highlighting the relationship between all 5mC and 5hmC samples according to the top 50% most variable probes in the 450 K array.
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dard 450 K data (Fig. 4D).
In order to determine the functional relevance of these dynamically
regulated loci, we used a method designed for the identiﬁcation of co-
variant molecular networks in gene expression data, weighted gene
correlation network analysis (WGCNA) [30]. Although this method
works best with linear scale gene expression data, running the current
analysis at a high, soft thresholding power permitted approximation
of the scale-free topology required of the technique (Fig. S3A–B,Supplementary Methods). We reasoned that through the identiﬁcation
of highly correlated patterns of dynamic methylation, the underlying
genomic regions would be enriched for genes converging on speciﬁc
pathways or biological processes critical in the establishment of the car-
diovascular and neural lineages.
Initially, we identiﬁed 10 modules of covariant cytosines that were
tested for functional enrichments using the genomic regions enrich-
ment of annotations tool (GREAT) [31]. Analysis of each module's asso-
ciated enrichments suggested that some modules could perhaps be
Fig. 4. Comparison of statistical results from analysis of standard 450 K array and TAB-array data. Venn diagrams were used to plot the overlap in signiﬁcantly dynamic loci identiﬁed in
standard 450 K array data and TAB-array data for (A) iPSC vs. CVPs, (B) iPSC vs. NPCs, (C) the union of these two analyses, and (D) probes that were ﬂagged as being overcorrected.
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targeted hierarchical clustering of cytosines within a given module,
we generated two subclusters from each of modules 1, 2, and 6 that
sharedmore functional enrichments compared to the completemodule
fromwhich theywere derived (Fig. S3C–E). In the end,we distinguished
13modules with distinct patterns of 5mC and 5hmC (Table S2). Most of
the 13 modules were dominated by processes relevant to pluripotent
stem cells or to the development of the cardiovascular and neural line-
ages. Five of these modules were particularly noteworthy (Fig. 5), al-
though many of the remaining modules were also interesting (Fig. S4).
In iPSCs, the cytosines comprisingModule 1b exhibited high levels of
5mC and low levels of 5hmC (Fig. 5A,C). Upon differentiation, 5mC
levels were dramatically reduced in both lineages, with concomitant
gains in 5hmC. Distribution of these data showed that CVP-5hmC levels
were signiﬁcantly higher than NPC-5hmC levels, with the median Beta
for CVPs greater than the third quartile in NPCs (Fig. 5C). As expected,
Module 1b was enriched for functions speciﬁc to derivatives of CVPs,
such as muscle contraction and cardiac muscle cell development
(Fig. 5B, Table S2). This pattern of dynamic methylation is consistent
with the establishment of lineage-speciﬁc euchromatin in a progenitor
cell type.
Module 2a was completely devoid of 5hmC in all cell types. Howev-
er, these cytosines exhibited very high levels of 5mC in iPSCs that were
reduced to very low levels in CVPs and completely abolished in NPCs
(Fig. 5A, Fig. 5C). This module was almost completely devoid of CpGs
(Fig. 6A) and contained a large number of genes categorized as cell-
cycle associated chromosome condensation and nucleocytoplasmic
protein transport (Fig. 5B, Table S2). Module 10 was also speciﬁc to un-
differentiated iPSCs, but was characterized by high levels of 5hmC and
low levels of 5mC (Fig. 5A,C). Upon differentiation, 5hmC levels were
diminished to low levels in CVPs and to slightly lower levels in NPCs. In-
triguingly, these cytosines were often found in genomic regions associ-
ated with Wnt signaling, which is critical to the exit from pluripotency
in the early stages of both CVP and NPC differentiation (Fig. 5B). There-
fore, we reasoned that this pattern of change is consistent with the pro-
posed role for 5hmC in developmental poising of lineage-specifying
factors.
Similar toModule 10, Module 4 cytosines had high levels of 5hmC in
iPSCs, but also had nearly equivalent levels of 5mC (Fig. 5A,C). Upon
differentiation, CVPs experienced highly signiﬁcant gains of 5mC and
losses of 5hmC, while both of these marks were signiﬁcantly reduced
in NPCs (Fig. 5C). These NPC-hypomethylated genomic regions were
dominated by neurodevelopmental processes, especially those associat-
ed with motor neuron differentiation and spinal cord development
(Fig. 5B, Table S2). Interestingly, the NPC differentiation protocol used
here has recently been shown to correct the paralytic effects in a
demyelinated mouse model of multiple sclerosis following NPC intra-
spinal transplantation [32]. Therefore, our epigenetic analyses are con-
sistent with experimental evidence that these NPCs are particularly
suited for stimulating spinal cord repair and gliogenesis.
The pattern of methylation in Module 7 was most clearly character-
ized by high levels of 5mC in NPCs (Fig. 5A). Additionally, we observed
intermediate levels of 5hmC in iPSCs that were slightly reduced in bothCVPs and NPCs upon differentiation (Fig. 5C). Surprisingly, the most
signiﬁcant enrichments for this module paralleled those of Module 4,
with several of the enrichment terms exactly matched between these
modules (Fig. 5B, red asterisks). Further, 13/59 genes within these
matched terms were associated with cytosines from both Module 4
and Module 7. Of these genes, 11/13 were potent lineage-specifying
transcription factors (DLX2, GLI3, HES1, LHX1, LHX5, NKX6-2, NR2F2,
PAX3, PAX6, SKI, SOX4) and two were critical players in neuronal devel-
opment and migration (COBL, RGMA). Given the disparate patterns of
methylation characteristic of Modules 4 and 7, we reasoned that the
cytosines within these modules must be distinguished by underlying
sequence determinants and/or genomic positioning relative to each as-
sociated gene's transcriptional start site (TSS). Examining the composi-
tion of thesemodules according to CpG density, we found thatModule 4
cytosines were primarily found in CpG-poor regions. Conversely,
Module 7 contained more cytosines in CpG dense regions and CpG
islands than any other module (Fig. 6B–C). Therefore, Module 4 and 7
cytosines can be distinguished according to CpG density.
Next we focused our analysis on 68 cytosines fromModules 4 and 7
thatwere associatedwith the overlapping set of 13 genes from the func-
tional enrichment results. Module 4 cytosines were nearly exclusively
found in regions 100–1000 kb upstream or 40–1000 kb downstream
of each genes TSS, with a single cytosine 20–30 kb upstream (Fig. 6D,
top). On the contrary, the vast majority of Module 7 cytosines were
localized to regions immediately downstream of the TSS (Fig. 6D,
bottom). The distinctions between Modules 4 and 7 are summarized
in a plot of 5mC Beta values for these 68 cytosines in iPSCs, CVPs and
NPCs according to the annotations from Fig. 6D (x-axis) and Fig. 6C
(split boxplots to color scale). Fig. 6E shows Module 4 cytosines within
CpG-poor gene distal regions, and Module 7 cytosines within CpG-rich
gene proximal regions downstream of the TSS. The pattern of dynamic
methylation in the distal and CpG-poor regions of Module 4 is consis-
tent with developmental poising in iPSCs (Fig. 5C, 6E). Upon differenti-
ation, these poised regions undergo heterochromatic resolution in CVPs
and euchromatic resolution in NPCs with concomitant increases in 5mC
methylation across gene body elements (Module 7).
3. Discussion
DNAmethylation is critical to the regulation of both developmental
and homeostatic processes. Well-established technologies have shed
light on how the interplay betweenDNAmethylation, histonemodiﬁca-
tions and non-coding RNA expression maintain the ﬁdelity required of
these processes. Recently, an oxidized derivative of DNA methylation,
5hmC, was found to be widespread throughout the genomes of hPSCs
and differentiated cell types, introducing a newmajor player in the reg-
ulation of epigenetics. To date, targeted studies of 5hmC have been lim-
ited, in part because these studies have relied on cost-prohibitive DNA
sequencing. Furthermore, discrimination of 5mC and 5hmC in sequenc-
ing data is inherently complex, requiring deconvolution of 4 distinct
signals from standard bisulﬁte (C, 5mC + 5hmC) and TAB-seq data
(C+ 5mC, and 5hmC). The cost required to generate these data and bio-
informatics expertise required to analyze them limit the accessibility of
Fig. 5. Functional enrichments for covariant DNA-methylation modules. Cytosines with signiﬁcant differences in either 5hmC or 5mC levels among iPSCs, CVPs and NPCs were identiﬁed
using Limma and subsequently binned into covariant modules using WGCNA. Beta values and functional enrichments for exemplary modules are shown. (A) Heatmap of Beta values for
cytosines in Modules 1b, 2a, 4, 7, and 10. (B) Functional enrichments for each module as determined by GREAT. 5mc Beta values are plotted from black to red and 5hmC Beta values are
plotted from black to cyan. For functional enrichments, both region and gene based fold-enrichment values are shown and the length of each bar represents the signiﬁcance of the enrich-
ment (-log10(binomial FDR)). (C) Box and whisker plots of Beta values of all cytosines in each of the modules in panels A–B. The corresponding data for modules not shown in this ﬁgure
are provided in Fig. S4.
364 K.L. Nazor et al. / Genomics 104 (2014) 358–3675hmC-targeted studies formany researchers. The TAB-arraymethod de-
scribed here will allow for the widespread incorporation of 5hmC-
targeted studies by the research community, providing a cost effective
means to generate single base resolution 5mC and 5hmC speciﬁc data
that can be easily analyzed within the R statistical environment.Our analysis of 5mC and 5hmC dynamics in the in vitro differentia-
tion of iPSCs into CVPs or NPCs highlights the utility of the TAB-array
method. At the most basic level, we were able to identify nearly twice
as many dynamically methylated cytosines in our differentiation
model compared to those identiﬁed by standard measures. More
Fig. 6.Deﬁnition ofDNAmethylationmodules according tomultiple parameters. Eachmodule composition is deﬁned according to (A) cytosine conﬁguration, (B) CpGdensity pentiles, and
(C) associationwith CpG islands. (D) Genomic position relative to the TSS of each cytosine's associated transcripts. (E) 5mC Beta values for the collection of cytosines associatedwith func-
tional enrichment terms that were signiﬁcant in bothModules 4 and 7. These data are plotted according to each cytosine's position relative to the transcriptional start site of its associated
transcript, and its association with CpG islands.
365K.L. Nazor et al. / Genomics 104 (2014) 358–367speciﬁcally, the discrimination of 5mC and 5hmC allowed for the iden-
tiﬁcation of complex patterns of these twomodiﬁcations that were sug-
gestive of their functional interplay. An example is the convergence of
methylation Modules 4 and 7 on genes associated with spinal cord
development. Within Module 4, CpG regions distal to spinal cord
genes appear poised, due to the presence of both 5mC and 5hmC at
these locations. Module 7, however, lacked appreciable levels of 5hmC
in iPSCs, but contained signiﬁcant gene body methylation in CpG
dense regions of the same spinal cord genes. An in vivo study in
mouse embryos showed 5hmC enrichment in gene bodies of genes as-
sociated with dorsal forebrain neuronal fates [33]. In contrast, we did
not observe 5hmC enrichment in gene bodies in our human NPCs in
any of the modules; however, this is not surprising, since the NPCs westudied were not forebrain precursors, but rather a unique in vitro pop-
ulation that was effective in restoring function in a model of multiple
sclerosis [32].
The implication of function for non-CpG methylation in pluripotent
stem cells is another example of the analytical strength afforded by
the TAB-array approach. Speciﬁcally, the sub-clustering of Module 2 to
generate Modules 2a and b was based on the absence of 5hmC at
cytosines from Module 2a. This distinction, which indicated a highly
signiﬁcant and uniform enhancement of genes regulating cell-cycle as-
sociated chromosome condensation and nucleocytoplasmic protein
transport, would not have been possible if the analysis were restricted
to standard 5mCdata from the450K array. In conclusion, our study sup-
ports diverse roles for 5hmC, with evidence of both developmental
366 K.L. Nazor et al. / Genomics 104 (2014) 358–367poising and establishment of euchromatin. Additionally, sequence
determinants such as CpG density, gene-relative genomic location and
cytosine conﬁguration (CpG vs CpH) underlie the localization of 5mC
vs 5hmC modiﬁcations in differentiating human cells.
4. Materials and methods
4.1. Cell culture and characterization
The iPSC line used for these studies was derived from dermal
ﬁbroblasts from donor 68 [34], using Sendai virus (Cytotune®, Life
Technologies) according to the manufacturer's instructions. Cells were
tested for pluripotency using embryoid body formation, teratoma
formation and PluriTest [35] (data not shown). Cells were adapted to
feeder-free conditions on Geltrex® (Life Technologies), expanded in
StemPro® culture medium (Life Technologies), and passaged with
Accutase (Life Technologies).
For differentiation into CVPs, iPSCs were seeded at 125,000 cells per
well of a 6well plate coatedwith bovine collagen type 1 (BDBioscience)
at 8 μg/cm2. Cells were cultured for 5 days in cardiac differentiation
medium (Genea Biocells), changing the medium every other day.
Differentiation of NPCs from iPSCs was carried out using a speciﬁc
protocol that produced cells that restored function after transplant to
a mouse model of multiple sclerosis [32]. Brieﬂy, 1X104 cells per cm2
were seeded on Matrigel (BD Biosciences)-coated 6 well plates in
StemPro® medium (Life Technologies) for 24 hours. The medium
was then changed to NPC differentiation medium which contains the
following: DMEM/F-12 (Life Technologies), 20% Knockout Serum Re-
placement (Life Technologies), 1X Glutamax™ (Life Technologies),
0.1 mM 2-mercaptoethanol (Life Technologies), 20 ng/mL midkine
(EMD-Millipore), 2 μM dorsomorphin (Sigma-Aldrich), 2 μM A 83-01
(Tocris), and 2 μM PNU-74654 (Sigma-Aldrich). Cells were Accutase®
passaged (1:3) on days 3 and 6 and harvested on day 9.
4.2. Immunocytochemistry
Cells were ﬁxed in 4% paraformaldehyde for 15 minutes at room
temperature. After blocking in 5% FBS, cells were incubated with
primary antibodies against Nanog (Cell Signaling, 1:400), SSEA4 (Cell
Signaling, 1:400), Pax6 (Developmental Studies Hybridoma Bank,
1:100) and Nestin (Millipore, 1:15000). Cells were incubated with
diluted secondary antibodies conjugated to AlexaFluor 488 and 555
(Life Technologies, 1:1000). Cells were washed twice and mounted
using 4',6-diamidino-2-phenylindole (DAPI)-containing Vectashield®
mounting medium (Vector Laboratories). For CVP immunolabeling,
cells were ﬁxed in formalin for 20 minutes and blocked in 1% BSA.
Cells were incubated with primary antibodies including Isl1/2 (Devel-
opmental Studies Hybridoma Bank, 1:200) or Nkx2.5 (Santa Cruz Bio-
technology, sc-14033, 1:200) at room temperature for 1 hour. Cells
were then incubated with secondary antibodies conjugated with
AlexaFluor 488 and 594 (Life technologies, 1:1000) for 1 hour at room
temperature.
4.3. DNA isolation
Twowells of a 6well platewere harvested to generate two biological
replicates for each sample type. Cells were removed from the dish using
Accutase and DNA was isolated using a DNeasy kit (Qiagen) according
to the manufacturer's recommendations. DNA was quantiﬁed using a
Qubit and dsDNA BR Reagent (Life Technologies).
4.4. TAB conversion
For Tet-Assisted bisulﬁte conversion, 1 μg of genomic DNA with
C/5mC/5hmC spike-in controls was ﬁrst sheared, then glucosylated
and oxidized as reported [14] before subsequent bisulﬁte treatment.The 1 μg of genomic DNA containing 0.5% M. SssI methylated lambda
DNA and 0.25% hydroxymethylated pUC19 control was sheared to an
average of 2,000 bp by sonication (Covaris). The glucosylation reaction
was performed in a 20 μl volume containing 50 mM HEPES (pH 8.0),
25 mMMgCl2, 50 ng/μl DNA, 200 mM UDP-Glc, and 2 μM βGT. The re-
action was incubated at 37 °C for 1 hr. The glucosylated DNA was puri-
ﬁedwith QIAquick PCR Puriﬁcation Kit (Qiagen). The oxidation reaction
was performed in two 50 μl aliquots containing 50mMHEPES (pH 8.0),
100 mM ammonium iron (II) sulfate, 1 mM α-ketoglutarate, 2 mM
ascorbic acid, 2.5 mM DTT, 100 mM NaCl, 1.2 mM ATP, 6 ng/μl
glucosylated DNA, and 5 μM recombinant Tet1. The reaction was incu-
bated at 37 °C for 75 min. After proteinase K treatment, the oxidized
DNA was puriﬁed with Micro Bio-Spin P-30 Gel Column (Bio-Rad)
and QIAquick PCR Puriﬁcation Kit (Qiagen).
4.5. Bisulﬁte conversion and DNA processing
TheBisulﬁte conversionwas performedusing the EZDNAMethylation
Kit (Zymo Research) according to themanufacturer's instructions. Whole
genome ampliﬁcation, fragmentation and preparation of the DNA for hy-
bridization were performed using the Inﬁnium HumanMethylation450
BeadChip kit (Illumina) as described in the manufacturer's protocol.
4.6. Data normalization
Illumina IDATS were read directly into R and normalized using
Subset-quantile within array normalization for illumina inﬁnium
HumanMethylation450 BeadChips. Details about the normalization
procedure and correction of 5mC Beta values are provided in the sup-
plementary methods.
4.7. Identiﬁcation of dynamic methylation
All analyses were performed using Limma in R. Details of these pro-
cedures are provided in the supplementary methods.
4.8. Identiﬁcation of DNAmethylationmodules and functional enrichments
DNA methylation modules were identiﬁed using WGCNA in R and
functional enrichments were identiﬁed using GREAT. Details of these
procedures are provided in the supplementary methods.
4.9. Data accession
Rawand normalized data have been deposited in theGEO repository
under the accession GSE60225.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.ygeno.2014.08.014.
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